Achmea Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$32.6M |
| 2 |
Workday
WDAY
|
+$17.9M |
| 3 |
Adobe
ADBE
|
+$10.1M |
| 4 |
Advanced Micro Devices
AMD
|
+$7.37M |
| 5 |
AT&T
T
|
+$7.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$16.6M |
| 2 |
Microsoft
MSFT
|
+$16M |
| 3 |
Target
TGT
|
+$11.5M |
| 4 |
Trane Technologies
TT
|
+$10.3M |
| 5 |
Ferguson
FERG
|
+$8.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Healthcare | 18.36% |
| 3 | Financials | 11.49% |
| 4 | Consumer Discretionary | 10.21% |
| 5 | Industrials | 8.53% |
Similar funds
Achmea Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Achmea Investment Management held 675 positions worth $2.83B, down 8.6% from $3.09B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Achmea Investment Management withdrew a net $146M in Q3 2022, closing 28 positions and reducing 250 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $7.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Achmea Investment Management opened a new position in AbbVie worth $30.5M.
- Achmea Investment Management's largest Q3 2022 buy was AbbVie: 227,376 shares worth $30.5M.
- Achmea Investment Management added most to Synopsys in Q3 2022, an estimated $5.91M increase.
- Achmea Investment Management's biggest Q3 2022 reduction was Apple, cutting an estimated $16.6M.
- Achmea Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q3 2022, selling an estimated $7.81M.
- Achmea Investment Management's ten largest holdings make up 24% of its $2.83B portfolio in Q3 2022.
- Achmea Investment Management opened 40 new positions and closed 28 in Q3 2022.
- Achmea Investment Management's portfolio value fell 8.6% quarter-over-quarter to $2.83B.
Based on Achmea Investment Management's 13F filing for Q3 2022, filed 27 Oct 2022.